147 related articles for article (PubMed ID: 17437612)
21. Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.
Oliveira SR; Flauzino T; Sabino BS; Kallaur AP; Alfieri DF; Kaimen-Maciel DR; Morimoto HK; de Almeida ERD; Lozovoy MAB; Reiche EMV; Dichi I; Simão ANC
Metab Brain Dis; 2018 Oct; 33(5):1393-1399. PubMed ID: 29797117
[TBL] [Abstract][Full Text] [Related]
22. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics.
Pasquali L; Pecori C; Lucchesi C; LoGerfo A; Iudice A; Siciliano G; Bonuccelli U
Clin Biochem; 2015 Jan; 48(1-2):19-23. PubMed ID: 25300461
[TBL] [Abstract][Full Text] [Related]
23. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
[TBL] [Abstract][Full Text] [Related]
24. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Mahfooz N; Carl E; Drake A; Schneider J; Teter B; Hussein S; Mehta B; Weiskopf M; Durfee J; Bergsland N; Ramanathan M
J Neuroinflammation; 2011 Oct; 8():127. PubMed ID: 21970791
[TBL] [Abstract][Full Text] [Related]
25. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
28. Prediction of long-term disability in multiple sclerosis.
Schlaeger R; D'Souza M; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
Mult Scler; 2012 Jan; 18(1):31-8. PubMed ID: 21868486
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
30. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
31. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
Young PJ; Lederer C; Eder K; Daumer M; Neiss A; Polman C; Kappos L;
Neurology; 2006 Sep; 67(5):804-8. PubMed ID: 16966541
[TBL] [Abstract][Full Text] [Related]
32. Self-rated physical health predicts change in disability in multiple sclerosis.
Drulovic J; Riise T; Nortvedt M; Pekmezovic T; Manigoda M
Mult Scler; 2008 Aug; 14(7):999-1002. PubMed ID: 18505776
[TBL] [Abstract][Full Text] [Related]
33. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
34. The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Ramanathan S; Lenton K; Burke T; Gomes L; Storchenegger K; Yiannikas C; Vucic S
J Clin Neurosci; 2013 Nov; 20(11):1576-81. PubMed ID: 23827173
[TBL] [Abstract][Full Text] [Related]
35. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients.
Ferretti G; Bacchetti T; DiLudovico F; Viti B; Angeleri VA; Danni M; Provinciali L
Neurochem Int; 2006 Jan; 48(2):87-92. PubMed ID: 16263194
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
[TBL] [Abstract][Full Text] [Related]
37. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
[TBL] [Abstract][Full Text] [Related]
39. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
[TBL] [Abstract][Full Text] [Related]
40. Gray matter damage predicts the accumulation of disability 13 years later in MS.
Filippi M; Preziosa P; Copetti M; Riccitelli G; Horsfield MA; Martinelli V; Comi G; Rocca MA
Neurology; 2013 Nov; 81(20):1759-67. PubMed ID: 24122185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
